AKCEA THERAPEUTICS, INC. (AKCA) has 17 open-market insider trades by 8 insiders since 2017. The most active filer is IONIS Pharmaceuticals Inc., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| IONIS Pharmaceuticals Inc. | 10% Owner | — | 3 | $1.2B | 2020-10-10 |
| Jeff Marc Goldberg | COO | — | 2 | $2.2M | 2019-09-26 |
| Paula Soteropoulos | CEO | — | 3 | $1.7M | 2019-09-26 |
| Damien McDevitt | CEO | — | 2 | $537K | 2020-10-12 |
| Sarah Boyce | Pres | — | 1 | $43K | 2019-07-15 |
| Louis O'Dea | Chief Medical Officer | — | 1 | $38K | 2020-03-23 |
| Kyle Jenne | Chief Commercial Officer | — | 2 | $22K | 2020-10-12 |
| Joshua F. Patterson | General Counsel | — | 3 | $13K | 2020-10-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| IONIS Pharmaceuticals Inc. | 10% Owner | Buy | $770.9M | 2020-10-10 |
| Joshua F. Patterson | General Counsel | Sell | $6K | 2020-09-22 |
| Damien McDevitt | CEO | Sell | $316K | 2020-09-22 |
| Kyle Jenne | Chief Commercial Officer | Sell | $13K | 2020-09-22 |
| Joshua F. Patterson | General Counsel | Sell | $3K | 2020-07-17 |
| Kyle Jenne | Chief Commercial Officer | Sell | $9K |
Companies that share insiders with AKCA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-03-23 |
| Damien McDevitt | CEO | Sell | $221K | 2020-03-23 |
| Joshua F. Patterson | General Counsel | Sell | $4K | 2020-03-23 |
| Louis O'Dea | Chief Medical Officer | Sell | $38K | 2020-03-23 |
| Sarah Boyce | President | Sell | $43K | 2019-07-15 |
| Paula Soteropoulos | CEO | Sell | $57K | 2019-04-08 |
| Jeff Marc Goldberg | COO | Sell | $634K | 2019-04-08 |
| Paula Soteropoulos | CEO | Sell | $1.1M | 2019-04-05 |
| Jeff Marc Goldberg | COO | Sell | $1.6M | 2019-04-05 |
| Paula Soteropoulos | CEO | Sell | $1.2M | 2019-03-06 |